Skip to main content
. 2021 Sep 17;8:723813. doi: 10.3389/fnut.2021.723813

Figure 5.

Figure 5

Mean absolute change (±SEM) in select EPA-derived oxylipins (nM) at 12 months of supplementation, according to APOE genotype and the level of baseline EPA. Low basal EPA (APOE3 n = 22, APOE4 n = 9), high basal EPA (APOE3 n = 18, APOE4 n = 10).